April 29, 2026

The European regulatory landscape is entering a decisive phase. With EUDAMED (European Database on Medical Devices) becoming fully operational and mandatory from May 28, 2026, it will serve as the central digital infrastructure for EU MDR (EU 2017/745) and IVDR (EU 2017/746) compliance.

This transition marks a shift toward end-to-end device traceability, real-time regulatory oversight, and enhanced transparency across the product lifecycle. For manufacturers, importers, and Authorized Representatives, EUDAMED is no longer optional, it is now the baseline requirement for EU market access.

From May 28, 2026, EUDAMED becomes mandatory for new medical devices and IVDs entering the EU market. Manufacturers must complete Actor Registration (SRN), UDI & Device Registration, Notified Body certification linkage, and Market Surveillance data integration before placing products on the market.

What Becomes Mandatory on May 28, 2026

From the enforcement date, all new medical devices and IVDs must be registered in EUDAMED prior to market placement, ensuring that regulators have centralized visibility into device data, certification status, and post-market performance.

Four Core EUDAMED Modules Going Live

1. Actor Registration Module (SRN)

Enables economic operators (manufacturers, ARs, importers) to obtain a Single Registration Number (SRN), a prerequisite for all further EUDAMED activities.

2. UDI & Device Registration Module

Ensure compliance with Unique Device Identification (UDI) requirements:

  • UDI-DI (Device Identifier) 
  • UDI-PI (Production Identifier) 
  • Device data submission aligned with GMDN/EMDN nomenclature

3. Notified Bodies & Certificates Module

Links:

  • CE certificates 
  • Conformity assessments 
  • Notified Body details 

Providing regulators with instant verification of certification status.

4. Market Surveillance Module

Supports:

  • Post-Market Surveillance (PMS) 
  • Vigilance reporting 
  • Trend analysis 

Strengthening ongoing device safety monitoring across the EU.

Why EUDAMED Is a Gamechanger for MedTech

Impact AreaWhat ChangesBusiness Implication
Market AccessMandatory pre-market registrationDelays if non-compliant
TraceabilityFull lifecycle visibilityImproved recall & safety actions
TransparencyPublic access to device dataIncreased accountability
ComplianceCentralized regulatory systemHigher audit readiness expectations

EUDAMED effectively becomes the single source of truth for EU device compliance.

EUDAMED Compliance Workflow for Manufacturers

StepActionOutcome
Step 1Actor RegistrationSRN generation
Step 2UDI AssignmentDevice identification compliance
Step 3Device Data UploadEUDAMED registration
Step 4Certificate LinkingValidation of conformity
Step 5PMS IntegrationContinuous compliance

Key Challenges Observed in 2026 Readiness

ChallengeDescriptionMitigation Strategy
SRN DelaysLate actor registrationInitiate immediately
UDI Data ComplexityIncorrect or incomplete dataValidate against standards
System IntegrationLack of IT readinessUse structured data workflows
Documentation GapsMisalignment with technical filesEnsure consistency

Best Practices to Achieve EUDAMED Readiness

1. Start with Actor Registration

Secure your SRN early to unlock all downstream activities.

2. Align UDI Strategy with Global Systems

Ensure harmonization with:

  • FDA UDI 
  • IMDRF guidelines 
  • Internal ERP systems 

3. Digitize Regulatory Data

Adopt:

  • Structured data formats 
  • Centralized documentation systems 
  • Automated validation checks 

4. Train Cross-Functional Teams

Ensure regulatory, quality, and IT teams are aligned on:

  • Data requirements 
  • Submission timelines 
  • Compliance responsibilities 

2026 Regulatory Trends Driving EUDAMED Adoption

  • Increased focus on digital compliance ecosystems 
  • Expansion of real-time regulatory oversight 
  • Greater emphasis on data transparency and traceability 
  • Alignment with global UDI frameworks (IMDRF) 

EUDAMED is not just a database it is the foundation of future EU MedTech regulation.

A Practical Compliance Perspective

Organizations that are successfully preparing for EUDAMED are those that treat it as a strategic transformation initiative, not just a regulatory task.

This involves:

  • Embedding EUDAMED processes into Quality Management Systems (ISO 13485) 
  • Aligning with risk management frameworks (ISO 14971) 
  • Maintaining accurate, audit-ready technical documentation
  • Establishing clear governance for data ownership and updates

This approach ensures consistency, reliability, and regulatory confidence during inspections and audits.

Conclusion

May 28, 2026, EUDAMED mandate represents a major milestone in EU MDR/IVDR implementation.

By requiring mandatory device registration, UDI compliance, and integrated market surveillance, the EU is reinforcing a data-driven, transparent, and patient-centric regulatory system.

Manufacturers that act early by aligning systems, processes, and teams will not only ensure compliance but also gain a competitive advantage in EU market access and operational efficiency.

FAQ

1. When does EUDAMED become mandatory?

EUDAMED becomes mandatory on May 28, 2026, for new medical devices and IVDs entering the EU market.

2. What is required for EUDAMED compliance?

  • Actor Registration (SRN) 
  • UDI & Device Registration 
  • Certificate linkage 
  • Market surveillance data 

3. Can devices be sold without EUDAMED registration after 2026?

No, registration is mandatory prior to market placement under MDR/IVDR requirements.

4. How should companies prepare?

By implementing:

  • UDI systems 
  • Regulatory data management 
  • EUDAMED submission workflows